JP6930693B2 - ジルチアゼムの非経口投薬形態 - Google Patents
ジルチアゼムの非経口投薬形態 Download PDFInfo
- Publication number
- JP6930693B2 JP6930693B2 JP2018528283A JP2018528283A JP6930693B2 JP 6930693 B2 JP6930693 B2 JP 6930693B2 JP 2018528283 A JP2018528283 A JP 2018528283A JP 2018528283 A JP2018528283 A JP 2018528283A JP 6930693 B2 JP6930693 B2 JP 6930693B2
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- dosage form
- diltiazem
- parenteral dosage
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
a)ジルチアゼムまたはその薬学的に許容可能な塩を含んでなるすぐに注入可能な安定した水溶液、pHの範囲を3〜5にするためのpH調整剤、およびエタノール、ならびに
b)当該水溶液で充填した注入容器
を含んでなる、非経口投薬形態を提供する。
以下の実施例I〜IVは、本発明の好ましい実施態様による非経口投薬形態を例証する。
以下の比較例A〜Eは、比較の非経口投薬形態を例証する。
Claims (6)
- a.ジルチアゼムまたはその薬学的に許容可能な塩、pHの範囲を3〜5にするためのpH調整剤、およびエタノールを含んでなるすぐに注入可能な安定した水溶液;ならびに
b.該水溶液で充填した注入容器
を含んでなり、
前記水溶液が、室温で少なくとも6か月、または2〜8℃で少なくとも6か月、あるいはその両方で安定であり、かつ、2%未満の脱アセチルジルチアゼム不純物を有し、
前記水溶液が、エタノール以外のアルコール共溶媒を含まず、非経口投与のための、非経口投薬形態。 - 前記ジルチアゼムまたはその薬学的に許容可能な塩が約0.4mg/ml〜1.0mg/mlの濃度で前記水溶液中に存在する、請求項1に記載の非経口投薬形態。
- エタノールが約1.0w/v%〜10.0w/v%の濃度の範囲で前記水溶液中に存在している、請求項1に記載の非経口投薬形態。
- 前記水溶液が、注入容器中に約50ml〜500mlの容積の範囲で存在している、請求項1に記載の非経口投薬形態。
- 前記注入容器がプラスチック製であり、かつ軟質である、請求項4に記載の非経口投薬形態。
- 前記水溶液が、室温で少なくとも6か月、または2〜8℃で少なくとも6か月、あるいはその両方で、2%未満の合計不純物の含量を有する、請求項1に記載の非経口投薬形態。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021124237A JP7262528B2 (ja) | 2015-12-01 | 2021-07-29 | ジルチアゼムの非経口投薬形態 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4533/MUM/2015 | 2015-12-01 | ||
IN4533MU2015 | 2015-12-01 | ||
PCT/IN2016/050429 WO2017094029A2 (en) | 2015-12-01 | 2016-12-01 | Parenteral dosage form of diltiazem |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021124237A Division JP7262528B2 (ja) | 2015-12-01 | 2021-07-29 | ジルチアゼムの非経口投薬形態 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018537468A JP2018537468A (ja) | 2018-12-20 |
JP6930693B2 true JP6930693B2 (ja) | 2021-09-01 |
Family
ID=58796480
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018528283A Active JP6930693B2 (ja) | 2015-12-01 | 2016-12-01 | ジルチアゼムの非経口投薬形態 |
JP2021124237A Active JP7262528B2 (ja) | 2015-12-01 | 2021-07-29 | ジルチアゼムの非経口投薬形態 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021124237A Active JP7262528B2 (ja) | 2015-12-01 | 2021-07-29 | ジルチアゼムの非経口投薬形態 |
Country Status (3)
Country | Link |
---|---|
US (1) | US11241379B2 (ja) |
JP (2) | JP6930693B2 (ja) |
WO (1) | WO2017094029A2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020170198A1 (en) | 2019-02-22 | 2020-08-27 | Sun Pharmaceutical Industries Limited | Infusion bag of midazolam for intravenous use |
WO2022058988A1 (en) * | 2020-09-21 | 2022-03-24 | Sun Pharmaceutical Industries Limited | Parenteral dosage form of diltiazem |
CN113476411A (zh) * | 2021-06-22 | 2021-10-08 | 海南锦瑞制药有限公司 | 注射用盐酸地尔硫卓冻干粉针剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5899471A (ja) * | 1981-12-07 | 1983-06-13 | Tanabe Seiyaku Co Ltd | ベンゾチアゼピン誘導体の新規製造法 |
USH1139H (en) | 1988-07-21 | 1993-02-02 | E. R. Squibb & Sons, Inc. | Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination |
US7243689B2 (en) | 2000-02-11 | 2007-07-17 | Medical Instill Technologies, Inc. | Device with needle penetrable and laser resealable portion and related method |
ZA200502121B (en) | 2002-09-03 | 2008-01-30 | Medical Instill Tech Inc | Sealed containers and methods of making and filling same |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
CN100427095C (zh) * | 2003-09-26 | 2008-10-22 | 苏州长征-欣凯制药有限公司 | 含有钙通道阻滞药地尔硫䓬稀释后供静脉注射的注射液 |
KR20080014056A (ko) | 2005-05-20 | 2008-02-13 | 오메로스 코포레이션 | 시클로옥시게나제 저해제 및 칼슘채널 길항제 조성물 및이의 비뇨기과 시술시의 용도를 위한 방법 |
CA2616392A1 (en) * | 2007-12-21 | 2009-06-21 | Pharmascience Inc. | Pharmaceutical delivery device |
CN102240262A (zh) * | 2010-05-14 | 2011-11-16 | 山东方明药业股份有限公司 | 盐酸地尔硫卓注射液及其制备方法 |
CA2876292A1 (en) | 2012-06-13 | 2013-12-19 | Dr. Py Institute Llc | Device with penetrable septum and closure, and needle |
-
2016
- 2016-12-01 WO PCT/IN2016/050429 patent/WO2017094029A2/en active Application Filing
- 2016-12-01 US US15/780,793 patent/US11241379B2/en active Active
- 2016-12-01 JP JP2018528283A patent/JP6930693B2/ja active Active
-
2021
- 2021-07-29 JP JP2021124237A patent/JP7262528B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
WO2017094029A3 (en) | 2017-08-17 |
US20200246254A1 (en) | 2020-08-06 |
JP7262528B2 (ja) | 2023-04-21 |
JP2021176896A (ja) | 2021-11-11 |
US11241379B2 (en) | 2022-02-08 |
WO2017094029A2 (en) | 2017-06-08 |
JP2018537468A (ja) | 2018-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6812094B2 (ja) | ノルエピネフリンの注射剤形 | |
JP7262528B2 (ja) | ジルチアゼムの非経口投薬形態 | |
US10869867B2 (en) | Intravenous infusion dosage form | |
WO2019164765A1 (en) | Ready-to-use dexmedetomidine compositions | |
EP3290025B1 (en) | Stable infusion dosage form of morphine | |
JP7182651B2 (ja) | ビンカアルカロイド薬の投薬形態 | |
WO2022167978A1 (en) | Oxytocin ready to infuse dosage form | |
WO2022058988A1 (en) | Parenteral dosage form of diltiazem | |
US9757352B2 (en) | Parenteral dosage form of amiodarone | |
US20220105000A1 (en) | Stable parenteral dosage form of pyrazolone derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191029 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200908 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210302 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210601 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210629 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20210713 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210728 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6930693 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20210726 |